Interview with Graham Warrellow by Isaac Bruce.
Following his academic studies at the University of Surrey (UK), Graham Warrellow entered the pharmaceutical industry to pursue a career at the forefront of drug discovery. Following successful spells at Wyeth, Celltech and Almirall, he joined UCB as the Vice President for Chemistry UK. Through this role and as a director at Cyclofluidic, a joint venture of UCB and Pfizer, he has witnessed changing trends in medicinal chemistry R&D over recent years. Dr Warrellow speaks to Isaac Bruce, Commissioning Editor, about industry collaborations, what qualities make for a good medicinal chemist and the future of the pharmaceutical industry.